Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials

20260 citationsJournal Articlegold Open Access

Authors

All three trials were registered with ClinicalTrials.gov (MIRA-2, NCT04620213; MIRA-3, NCT05134974; MIRA-4, NCT05223478).

Good health and well-being

Published in: Clinical ophthalmology

Volume Volume 20, pp. 1-13

Field-Weighted Citation Impact: 0.00